Efforts to identify people at a very high cancer risk and likely to benefit from and not be harmed by particular agents will be crucial to the future of cancer prevention. |
First, we must do no harm. |
Great clinical strides have been made in breast, colorectal and prostate cancer prevention. |
M. D. Anderson is a world leader in research to better understand agent mechanisms. And this research will hasten the arrival of safe and effective preventive drugs into the hands of the people who need them. |